Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Pacific Biosciences Clocks 14% Jump In Q1 Revenues

Pacific Biosciences of California Inc's (NASDAQ:PACB) Q1 sales increased 14% Y/Y to $33.2 million, driven by sales of instruments and consumables and beating the consensus of $32.82 million. Instrument revenue was $15.6 million, compared with $14.9 million a year ago. Consumables revenue was $12.7 million, up from $10.4 million in Q1 2021.…

Benzinga

Why AMC-Related Stock Hycroft Mining Is Popping Off

Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares are trading higher by 27.92% at $1.79 after the company reported first-quarter earnings results.

Benzinga

Papa John's Q1 Earnings Exceed Expectations

Papa John's International Inc (NASDAQ:PZZA) reported first-quarter FY22 sales growth of 6% year-on-year to $542.69 million, beating the consensus of $540.39 million. Adjusted EPS of $0.95 topped the Street view of $0.94. Total comparable sales growth was 1.6% versus 25.4% the prior year. Comparable sales improved 1.9% in North America and 0.8% Internationally.…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Move Over Siri And Alexa, It's Time to Say 'Hey Sonos!'

Audio products company Sonos, Inc. (NASDAQ: SONO) is stepping into the league of the big boys with the anticipated launch of its voice assistant.

Benzinga

Why Fortinet Stock Is Trading Higher Today

Fortinet Inc (NASDAQ: FTNT) shares are trading higher THursday after the company reported better-than-expected financial results and issued guidance above analyst estimates.

Benzinga

Charles & Colvard: Q3 Earnings Insights

Charles & Colvard (NASDAQ:CTHR) reported its Q3 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Arbutus Biopharma: Q1 Earnings Insights

Arbutus Biopharma (NASDAQ:ABUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

World Acceptance: Q4 Earnings Insights

World Acceptance (NASDAQ:WRLD) reported its Q4 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Why Etsy Shares Are Falling

Etsy Inc (NASDAQ: ETSY) shares are trading lower by 13.58% at $94.50 after the company reported first-quarter earnings results and issued second-quarter sales guidance below analyst estimates.

Benzinga

Recap: Lifetime Brands Q1 Earnings

Lifetime Brands (NASDAQ:LCUT) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Concert Pharma: Q1 Earnings Insights

Concert Pharma (NASDAQ:CNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Nikola Q1 Earnings

Nikola (NASDAQ:NKLA) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Laureate Education Q1 Earnings

Laureate Education (NASDAQ:LAUR) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Myriad Genetics Q1 Earnings

Myriad Genetics (NASDAQ:MYGN) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:05 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Arm China Fires CEO But He Refuses To Just Pack His Bags And Leave

Arm China — a Shanghai-based joint venture between Arm Ltd and Chinese private equity firm Hopu Investment — on Thursday said its former CEO Allen Wu was refusing to relinquish his role despite being fired last week.

Benzinga

Recap: AVEO Pharmaceuticals Q1 Earnings

AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

WM Technology Posts Higher Net Loss, Negative Adjusted EBITDA In Q1

Cannabis tech provider WM Technology Inc. (NASDAQ: MAPS), d.b.a. Weedmaps, announced Wednesday its financial results for the first quarter ended March 31, 2022, revealing revenue growth of 40% year-over-year to $57.5 million.

Benzinga

Why Sunrun Shares Are Rising

Sunrun Inc (NASDAQ: RUN) shares are trading higher by 8.30% to $26.36 after the company reported better-than-expected first-quarter sales results.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Lazydays Hldgs: Q1 Earnings Insights

Lazydays Hldgs (NASDAQ:LAZY) reported its Q1 earnings results on Thursday, May 5, 2022 at 09:30 AM. Here's what investors need to know about the announcement.

Benzinga

Ironwood Pharmaceuticals: Q1 Earnings Insights

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Insight Enterprises Q1 Earnings

Insight Enterprises (NASDAQ:NSIT) reported its Q1 earnings results on Thursday, May 5, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Radius Health Q1 Earnings

Radius Health (NASDAQ:RDUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Lancaster Colony Q3 Earnings

Lancaster Colony (NASDAQ:LANC) reported its Q3 earnings results on Thursday, May 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Mirum Pharmaceuticals Q1 Earnings

Mirum Pharmaceuticals (NASDAQ:MIRM) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

C4 Therapeutics: Q1 Earnings Insights

C4 Therapeutics (NASDAQ:CCCC) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

1 … 552 553 554 555

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.